ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,937Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 252

$1.36M Total Retail Price of All Prescriptions

Rank: 4 out of 252

635 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 635 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 635 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 21,597 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 1,011 881 1 7
LISINOPRIL 880 756 2 3
SIMVASTATIN 810 647 3 2
LEVOTHYROXINE SODIUM 757 647 4 1
AMLODIPINE BESYLATE 747 651 5 4
POTASSIUM CHLORIDE 733 654 6 8
WARFARIN SODIUM 696 608 7 14
GABAPENTIN 503 395 8 11
OMEPRAZOLE 487 423 9 6
METFORMIN HCL 456 327 10 9
HYDROCODONE-ACETAMINOPHEN 428 357 S3 11 5
ATORVASTATIN CALCIUM 388 319 12 16
DONEPEZIL HCL 364 364 13 28
CITALOPRAM HBR 329 295 14 15
CARVEDILOL 325 296 15 22
SERTRALINE HCL 315 274 16 27
METOPROLOL TARTRATE 304 225 17 10
NAMENDA 284 269 18 41
ESCITALOPRAM OXALATE 276 213 19 56
LANTUS 265 200 20 55
CLONIDINE HCL 259 246 21 35
CLOPIDOGREL 255 215 22 29
POLYETHYLENE GLYCOL 3350 241 187 23 67
HYDROCHLOROTHIAZIDE 239 217 24 13
ALLOPURINOL 236 194 25 30
TRAMADOL HCL 233 192 26 17
RISPERIDONE 231 184 27 81
ATENOLOL 229 219 28 18
PRAVASTATIN SODIUM 224 200 29 12
TAMSULOSIN HCL 208 176 30 26
MELOXICAM 202 155 31 20
AMIODARONE HCL 188 180 32 142
CRESTOR 185 173 33 34
NOVOLOG 180 155 34 106
ISOSORBIDE MONONITRATE ER 167 146 35 50
ACETAMINOPHEN-CODEINE 161 152 S3 36 117
QUETIAPINE FUMARATE 150 136 37 77
METOPROLOL SUCCINATE 144 132 38 19
ALBUTEROL SULFATE 141 133 39 170
GLIPIZIDE 141 117 39 52
PERMETHRIN 140 125 41 265
PHENYTOIN SODIUM EXTENDED 139 122 42 103
DIGOXIN 137 124 43 44
ZOLPIDEM TARTRATE 135 121 44 21
PLAVIX 134 122 45 43
PREDNISONE 131 115 46 42
DIVALPROEX SODIUM 131 93 46 113
NEXIUM 128 110 48 23
ROPINIROLE HCL 127 113 49 84
KLOR-CON M20 117 78 50 69
MIRTAZAPINE 116 115 51 58
ALENDRONATE SODIUM 115 85 52 32
AMITRIPTYLINE HCL 111 98 R 53 46
FLUTICASONE PROPIONATE 110 89 54 36
SPIRIVA 110 106 54 68
ADVAIR DISKUS 106 93 56 63
RANITIDINE HCL 104 88 57 48
SPIRONOLACTONE 102 66 58 53
TIZANIDINE HCL 102 28 58 129
JANUVIA 95 69 60 88
TRIAMCINOLONE ACETONIDE 95 78 60 147
CYMBALTA 94 73 62 45
TERAZOSIN HCL 93 93 63 94
LEVOFLOXACIN 91 83 64 79
TRAZODONE HCL 89 74 65 31
PREMARIN 88 45 R 66 116
LEVEMIR 87 87 67 180
LIPITOR 86 70 68 112
CEPHALEXIN 86 72 68 121
LEXAPRO 84 60 70 224
GLIPIZIDE ER 84 59 70 90
DIOVAN HCT 84 73 70 65
PROMETHAZINE HCL 83 45 R 73 85
CIPROFLOXACIN HCL 81 72 74 61
HUMULIN R 79 38 75 202
NITROFURANTOIN MONO-MACRO 79 66 75 261
AZITHROMYCIN 79 61 75 37
FAMOTIDINE 79 67 75 59
OXYBUTYNIN CHLORIDE 79 48 75 123
ENALAPRIL MALEATE 77 65 80 72
HYDRALAZINE HCL 77 77 80 95
DIOVAN 76 76 82 38
DILTIAZEM 24HR CD 75 75 83 104
TRIAMTERENE-HCTZ 75 35 83 33
BENAZEPRIL HCL 75 75 83 80
IPRATROPIUM-ALBUTEROL 75 72 83 155
CYCLOBENZAPRINE HCL 73 53 R 87 51
QUINAPRIL HCL 71 71 88 120
CARBIDOPA-LEVODOPA 71 71 88 107
PROPRANOLOL HCL 70 65 90 111
SANTYL 70 59 90 311
OLANZAPINE 70 52 90 191
OXYBUTYNIN CHLORIDE ER 70 56 90 181
SEROQUEL 69 66 94 149
FLUOXETINE HCL 69 62 94 57
CARAFATE 68 55 96 250
METOCLOPRAMIDE HCL 68 36 96 110
AMLODIPINE BESYLATE-BENAZEPRIL 67 62 98 60
GLIMEPIRIDE 67 60 98 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 44 98 87
VALPROIC ACID 65 39 101 318
RAMIPRIL 62 41 102 71
LOSARTAN-HYDROCHLOROTHIAZIDE 61 61 103 49
PANTOPRAZOLE SODIUM 61 60 103 62
LOSARTAN POTASSIUM 61 58 103 24
NYSTOP 61 59 103 225
FENOFIBRATE 60 22 107 64
VENTOLIN HFA 58 50 108 102
LEVETIRACETAM 58 36 108 131
DILTIAZEM ER 56 56 110 86
LABETALOL HCL 55 48 111 150
ZETIA 55 42 111 97
INSULIN SYRINGE 54 39 113 93
DETROL LA 53 44 114 178
NOVOLIN 70-30 53 37 114 232
KLOR-CON M10 52 52 116 152
LANTUS SOLOSTAR 52 23 116 109
CEFUROXIME 52 40 116 114
BENICAR 51 47 119 143
BUSPIRONE HCL 51 38 119 119
BYSTOLIC 51 51 119 99
LYRICA 51 47 119 66
PROAIR HFA 50 44 123 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.